Along with Helsinn Advanced Synthesis S.A., Biasca, Switzerland, Helsinn Birex Pharmaceuticals Ltd, Mulhuddart, Dublin, founded in 1990, represents Helsinn’s Manufacturing Operations today.

All Helsinn manufacturing plants are approved by the Swiss and Irish authorities and by the US FDA, EMA, PIC and Japanese PMDA as well as by several other national boards.

The Irish plant is also accredited to ISO 14001 and has achieved recognition for the HSE management systems, including the recent 2009 best award of the Irish Responsible Care program.

In 2009 the Helsinn Group started the investment of over EUR 13 million, with the support of the Irish Development Authority (IDA), to build a Centre-of-excellence in Research and Development for Oral Solid Dosage forms at the Irish facility.

• Site covers area of 7.100m².
• Oral solid dosage forms, topical forms and packaging of sterile products, worldwide logistic platform.